Kezar Life Sciences, Inc. (Nasdaq: KZR), a clinical-stage biotechnology company discovering and developing breakthrough treatments for immune-mediated and oncologic disorders, today highlighted data from the Phase 1b portion of the MISSION study demonstrating safety, tolerability and early efficacy signals of KZR-616 in patients with systemic lupus erythematosus (SLE) and lupus… Read More..

Continues the Company’s Residential Expansion in (North) Mason County Gig Harbor, Washington , Sept. 17, 2020 (GLOBE NEWSWIRE) -- Harbor Custom Development, Inc. (“Harbor” or the “Company”), (NASDAQ: HCDI), an innovative and market leading real estate company involved in all aspects of the land development cycle, today announced that it… Read More..

NAPLES, Fla., Sept. 17, 2020 /PRNewswire/ -- HealthLynked Corp. (OTCQB: HLYK), a global healthcare network focused on care management of its members and healthcare technologies connecting doctors, patients and medical data, today announced the launch of its new podcast on iTunes, Google, and Spotify. HealthLynked's CEO, Dr. Michael Dent, stated,… Read More..